Vanguard Capital Management
DERM icon

Vanguard Capital Management’s Journey Medical DERM Stock Holding History

Vanguard Capital Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.78M Sell
675,185
-406,895
-38% -$2.32M ﹤0.01% 3140
2026
Q1 		$5.07M Buy
+1,082,080
New +$8.4M ﹤0.01% 3052

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management's DERM Position: Q2 2026 in Review

Vanguard Capital Management reduced its Journey Medical (DERM) stake by 38% in Q2 2026, selling an estimated $2.32M and leaving 675,185 shares worth $4.78M. The position accounts for ﹤0.01% of the portfolio, ranked #3140.

Vanguard Capital Management first reported a position in DERM in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.07M in Q1 2026. 62 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Vanguard Capital Management held 675,185 shares of Journey Medical worth $4.78M as of Q2 2026.
  • Vanguard Capital Management sold 406,895 Journey Medical shares in Q2 2026, an estimated $2.32M.
  • Journey Medical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3140 holding.
  • Vanguard Capital Management first reported a position in Journey Medical in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Journey Medical position peaked at $5.07M in Q1 2026.
  • 62 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.